PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Clinical trials for PSP - PROGRESSIVE SUPRANUCLEAR PALSY explained in plain language.
Never miss a new study
Get alerted when new PSP - PROGRESSIVE SUPRANUCLEAR PALSY trials appear
Sign up with your email to follow new studies for PSP - PROGRESSIVE SUPRANUCLEAR PALSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare brain disorder: experimental drug enters testing
Disease control Not yet recruitingThis clinical trial is testing whether an experimental drug called LM11A-31 can slow down Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. The study will involve 147 people with early-stage PSP who can still walk with minimal assistance. Participants will …
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New shot aims to slow devastating brain disease
Disease control Not yet recruitingThis study is testing an investigational drug called AADvac1 to see if it is safe and can slow the progression of Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. About 146 people with early-stage PSP will be randomly assigned to receive either the active …
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC